Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01YKI
|
|||
| Former ID |
DIB003601
|
|||
| Drug Name |
ANX-510
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 3 | [1] | |
| Company |
ADVENTRX Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H23N7O6
|
|||
| Canonical SMILES |
C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O
|
|||
| InChI |
1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t12?,13-/m0/s1
|
|||
| InChIKey |
QYNUQALWYRSVHF-ABLWVSNPSA-N
|
|||
| CAS Number |
CAS 3432-99-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:20502
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00337389) Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.